King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope

April 1, 2019 updated by: Doug Hester, Vanderbilt University

King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope: A Comparative Study in Ambulatory Surgery Center Patients

The investigators plan to conduct a randomized trial comparing the intubation success rate and time of the King Vision Video Laryngoscope to the Glidescope video laryngoscope in order to demonstrate the comparability of the devices.

Study Overview

Detailed Description

Both the King Vision and Glidescope video laryngoscopes are advanced airway devices that are relatively low cost and are designed to improve the efficiency of both routine and difficult intubation. Both systems use disposable blades, which eliminates the need for blade sterilization and may minimize the risk of infectious exposure to patients and improve cost and efficiency associated with the sterilization processing of non-disposable laryngoscopes. The Glidescope has been commercially available longer than the King Vision, and has been more frequently studied.

Although similar in many respects, the King Vision and Glidescope systems have differing designs which may result in differences in speed and success in the management of routine and/or difficult airways.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients scheduled for elective, ambulatory surgery requiring general anesthesia and endotracheal intubation

Exclusion Criteria:

  • Patients who require rapid sequence induction and intubation or fiberoptic intubation.
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: King Vision Video Laryngoscope
The patient would be randomized to intubation via use of the King Vision VL
Intubation via King Vision Video Laryngoscope
Other Names:
  • King Systems
Active Comparator: Glidescope Video Laryngoscope
The patient would be randomized to intubation via use of the Glidescope VL
Intubation via Glidescope Video Laryngoscope
Other Names:
  • Verathon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time Until Intubation With Each Device
Time Frame: <100 seconds
time from the introduction of the laryngoscope into the oral cavity to endotracheal tube reaching the glottic aperture
<100 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Pulse Oximetry Saturation Value Reading During Intubation
Time Frame: <100 seconds
<100 seconds
Total Number of Assisted Maneuvers Required to Complete Intubation (Includes All Participants in Arm)
Time Frame: <100 seconds
Assisted Maneuvers can include laryngeal manipulation, head lift, Backward Upward Rightward Pressure, stylet removed, Cricoid pressure, scope manipulation and bougie.
<100 seconds

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Adverse Events
Time Frame: during and immediately after procedure (approx 180 minutes)
Notation of any injury to lips, teeth, soft tissue.
during and immediately after procedure (approx 180 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas Hester, MD, Vanderbilt University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

October 1, 2017

Study Completion (Actual)

October 1, 2017

Study Registration Dates

First Submitted

December 18, 2014

First Submitted That Met QC Criteria

December 23, 2014

First Posted (Estimate)

December 24, 2014

Study Record Updates

Last Update Posted (Actual)

April 23, 2019

Last Update Submitted That Met QC Criteria

April 1, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 130470

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Difficult Intubation

Clinical Trials on King Vision Video Laryngoscope

Subscribe